Impact of age on clinicopathological outcomes and recurrence-free survival after the surgical management of nonseminomatous germ cell tumour

BJU International

Volumn 110, Issue 7, 2012, Pages 950-955

  Masterson, Timothy A ^a,b   Carver, Brett S ^a   Abel, E Jason ^a   Pettus, Joseph A ^a   Bosl, George J ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

age; nonseminomatous germ cell tumour; retroperitoneal lymph node dissection; testis cancer

Indexed keywords

ADULT; AGE; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURGICAL RISK; AGED; CANCER STAGING; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; PATHOLOGY; PROSPECTIVE STUDY; TESTIS TUMOR; TUMOR RECURRENCE;

ADULT; AGE FACTORS; AGED; BLOOD LOSS, SURGICAL; DISEASE-FREE SURVIVAL; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROSPECTIVE STUDIES; TESTICULAR NEOPLASMS;

EID: 84873260337     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.10947.x     Document Type: Article

References (14)

1. Bosl GJ, Motzer RJ,. Testicular germ-cell cancer. N Engl J Med 1997; 337: 242-53
2. Huyghe E, Matsuda T, Thonneau P,. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003; 170: 5-11
3. Steele GS, Richie JP, Stewart AK, Menck HR,. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996. Cancer 1999; 86: 2171-83
4. Bosl GJ, Gluckman R, Geller NL, et al,. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. J Clin Oncol 1986; 4: 1493-9
5. Einhorn LH,. Testicular cancer as a model for a curable neoplasm: the richard and hinda rosenthal foundation award lecture. Cancer Res 1981; 41: 3275-80
6. Carver BS, Serio AM, Bajorin D, et al,. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J Clin Oncol 2007; 25: 5603-8
7. Spermon JR, Witjes JA, Kiemeney LA,. Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor. Urology 2002; 60: 889-93
8. Berkman B, Rohan B, Sampson S,. Myths and biases related to cancer in the elderly. Cancer 1994; 74 (Suppl.): 2004-8
9. Bennett CL, Greenfield S, Aronow H, Ganz P, Vogelzang NJ, Elashoff RM,. Patterns of care related to age of men with prostate cancer. Cancer 1991; 67: 2633-41
10. Schonwetter RS,. Primary care cancer epidemiology, prevention and screening. In, Herold AH, ed, Geriatric Oncology, Philadelphia, PA: Saunders, 1992: 451-61
11. Butler RN, Gastel B,. Aging and cancer management. Part II: research perspectives. CA Cancer J Clin 1979; 29: 333-40
12. Peterson BA, Kennedy BJ,. Aging and cancer management. Part I: clinical observations. CA Cancer J Clin 1979; 29: 322-32
13. Goodwin JS, Samet JM, Hunt WC,. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996; 88: 1031-8
14. Inci K, Dogan HS, Akdogan B, Ergen A, Tasar C, Ozen H,. Does age affect the prognosis of patients with testicular germ cell tumor? Urol Int 2007; 79: 117-23